首页|腹腔镜子宫肌瘤剔除术瑞芬太尼联合环泊酚麻醉对患者血流动力学及炎症因子影响

腹腔镜子宫肌瘤剔除术瑞芬太尼联合环泊酚麻醉对患者血流动力学及炎症因子影响

扫码查看
目的:探讨瑞芬太尼联合环泊酚对腹腔镜子宫肌瘤剔除术患者血流动力学指标及炎症因子水平的影响.方法:将2022年10月-2023年9月本院收治的110例腹腔镜子宫肌瘤剔除术患者随机分成两组各55例,分别予以瑞芬太尼联合丙泊酚麻醉(丙泊酚组)或瑞芬太尼联合环泊酚麻醉(环泊酚组).观察患者血流动力学指标、苏醒质量、炎症因子水平、认知功能(MMSE评分)以及不良反应.结果:环泊酚组T1~T7的平均动脉压、心率、血氧饱和度均高于丙泊酚组,自主呼吸恢复(5.25±1.29 min)、苏醒(7.21±1.86 min)、定向力恢复(20.56±2.83 min)以及拔管时间(24.37±3.01 min)均短于丙泊酚组(7.33±1.85 min、12.82±2.23 min、25.38±3.71 min、32.62±3.67 min);术后 1d 两组白介素-6、肿瘤坏死因子-α均升高但环泊酚组(71.53±10.02 ng/L、12.23±2.96 ng/L)低于丙泊酚组(90.24±12.84 ng/L、17.65±3.58 ng/L),两组MMSE评分均降低但环泊酚组(27.04±1.00分)高于丙泊酚组(25.15±1.17分);环泊酚组不良反应发生率(5.5%)低于丙泊酚组(18.2%)(均P<0.05).结论:瑞芬太尼联合环泊酚用于腹腔镜子宫肌瘤剔除术麻醉,有助于稳定患者术中血流动力学指标,提高苏醒质量,减轻炎症反应与认知功能损伤,不良反应降低.
Effects of remifentanil combined with ciprofol for anesthesia during laparoscopic myomectomy of patients on their hemody-namic parameters and inflammatory factors levels
Objective:To explore the effects of remifentanil combined with ciprofol for anesthesia during laparoscopic myomectomy of patients on their hemodynamic parameters and inflammatory factors levels.Methods:110 patients who wanted laparoscopic myomectomy were randomly divided into group A and group B(55 cases in each group)from October 2022 to September 2023.The patients in group A received anesthesia with remifentanil combined with ciprofol during operation,while the patients in group B received anesthesia with remifentanil combined with propofol during op-eration.The hemodynamic indicators,the awakening quality,the inflammatory factor levels,the cognitive function(MMSE score)and the adverse reactions of the patients in the two groups were observed.Results:The values of the mean arterial pressure,the heart rate and the blood oxygen saturation of the patients in group A were significantly higher than those of the patients in group B.The time of the spontaneous breathing recovery(5.25±1.29 min),the a-wakening time(7.21±1.86 min),the orientation recovery time(20.56±2.83 min)and the extubation time(24.37± 3.01 min)of the patients in group B were significantly shorter than those(7.33±1.85 min,12.82±2.23 min,25.38± 3.71 min and 32.62±3.67 min)of the patients in group B.The levels of interleukin-6 and tumor necrosis factor-α of the patients in the two groups in 1 day after operation had increased significantly,but which(71.53±10.02 ng/L and 12.23 ±2.96 ng/L)of the patients in group A were significantly lower than those(90.24±12.84 ng/L and 17.65±3.58 ng/L)of the patients in group B.The MMSE score of the patients in the two groups had decreased significantly,but which(27.04±1.00 points)of the patients in group A was significantly higher than that(25.15±1.17 points)of the patients in group B.The incidence of the adverse reactions(5.5%)of the patients in group A was significantly lower than that(18.2%)of the patients in group B(all P<0.05).Conclusion:The application of remifentanil combined with ciprofol in the laparoscopic uterine myomectomy of the patients can help to stabilize their intraoperative hemodynamic indica-tors,improve their awakening quality,reduce their inflammatory reactions and cognitive impairment,and with the fe-wer adverse reactions.

Laparoscopic myomectomyRemifentanilCiprofolHemodynamic indicatorInflammatory factorA-wakening qualityAdverse reaction

邱光须、阮云、黄娟珍、陈文斌

展开 >

宁德师范学院附属宁德市医院(352100)

腹腔镜子宫肌瘤剔除术 瑞芬太尼 环泊酚 血流动力学指标 炎症因子 苏醒质量 不良反应

2024

中国计划生育学杂志
国家人口计生委科学技术研究所

中国计划生育学杂志

CSTPCD
影响因子:1.759
ISSN:1004-8189
年,卷(期):2024.32(4)
  • 22